老年女性接种牛津-阿斯利康 COVID-19 疫苗（AZD1222）后出现 Sweet 综合征。
Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.
机构信息
Cutis Institute of Dermatology, Srinagar, India.
出版信息
Dermatol Ther. 2021 Nov;34(6):e15146. doi: 10.1111/dth.15146. Epub 2021 Oct 7.
Abstract
Vaccination for COVID19 infection is in full swing all around the world and while the vaccines are considered overall safe, many cutaneous and extracutaneous adverse effects have been reported after their use. Local injection-site reactions are the commonest adverse effect described with the use of these vaccines. We describe a case of Sweet syndrome in an elderly female after the first dose of Oxford-AstraZeneca COVID-19 vaccine (AZD1222).
摘要
全球范围内正在全面开展针对 COVID19 感染的疫苗接种工作，虽然这些疫苗总体上被认为是安全的，但在使用后仍有许多皮肤和非皮肤的不良反应报告。这些疫苗使用后最常见的不良反应是局部注射部位反应。我们描述了一例老年女性在接种第一剂牛津-阿斯利康 COVID-19 疫苗（AZD1222）后出现的Sweet 综合征。
相似文献
1
Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.老年女性接种牛津-阿斯利康 COVID-19 疫苗（AZD1222）后出现 Sweet 综合征。
Dermatol Ther. 2021 Nov;34(6):e15146. doi: 10.1111/dth.15146. Epub 2021 Oct 7.
2
Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.新型冠状病毒牛津阿斯利康疫苗接种后出现的大疱性斯威特综合征。
Br J Dermatol. 2022 Mar;186(3):e110. doi: 10.1111/bjd.20876. Epub 2021 Nov 24.
3
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
4
Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.接种阿斯利康 ChAdOx1 nCoV-19（AZD1222）疫苗后出现伴血小板减少的血栓形成综合征（TTS）- 澳大利亚<60 岁人群的风险-效益分析。
Vaccine. 2021 Aug 9;39(34):4784-4787. doi: 10.1016/j.vaccine.2021.07.013. Epub 2021 Jul 10.
5
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.接种 SARS-CoV-2 疫苗后的皮肤反应：一项对 405 例病例的西班牙全国性横断面研究。
Br J Dermatol. 2022 Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21.
6
Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia.沙特阿拉伯 ChAdOx1（AZD1222）COVID-19 疫苗的安全性和反应原性。
Int J Infect Dis. 2021 Sep;110:359-362. doi: 10.1016/j.ijid.2021.07.052. Epub 2021 Jul 25.
7
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.接种 2019 年冠状病毒病（SARS-CoV-2）疫苗后发生 MOG 脑炎：病例报告及文献综述。
J Neurol. 2022 Oct;269(10):5198-5212. doi: 10.1007/s00415-022-11194-9. Epub 2022 Jun 23.
8
SARS-CoV-2 vaccine induced Sweet syndrome : a case report.SARS-CoV-2 疫苗诱发 Sweet 综合征：一例报告。
Tunis Med. 2021;99(12):1188-1191.
9
AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.阿斯利康（AZD1222）新冠疫苗相关药品不良事件：一例病例报告。
J Med Virol. 2021 Oct;93(10):5718-5720. doi: 10.1002/jmv.27175. Epub 2021 Jul 8.
10
Humoral immune response after different SARS-CoV-2 vaccination regimens.不同 SARS-CoV-2 疫苗接种方案后的体液免疫应答。
BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.
引用本文的文献
1
Sweet syndrome following the ChAdOx1-S vaccine.接种 ChAdOx1-S 疫苗后出现 Sweet 综合征。
BMJ Case Rep. 2024 Jan 12;17(1):e257635. doi: 10.1136/bcr-2023-257635.
2
Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.由新冠病毒辉瑞-生物科技mRNA疫苗诱发的复发性巨细胞性蜂窝织炎样斯威特综合征
Dermatol Reports. 2023 May 23;15(3):9668. doi: 10.4081/dr.2023.9668. eCollection 2023 Sep 12.
3
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.2019冠状病毒病疫苗诱导的皮肤并发症的管理：一项全面的文献综述。
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
4
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
5
Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies.新冠病毒疫苗引起的Sweet 综合征：患者报告研究的系统评价。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2217076. doi: 10.1080/21645515.2023.2217076.
6
Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review.COVID-19 疫苗的水疱性和其他皮肤表现：范围界定和叙述性综述。
J Cutan Med Surg. 2023 May-Jun;27(3):260-270. doi: 10.1177/12034754231156561. Epub 2023 Feb 15.
7
Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.S SARS-CoV-2 vaccination and review of literature.Ad26.COV2.S 疫苗接种引起的 Sweet 综合征伴结节性红斑和口腔溃疡的非典型表现，并复习文献。
Dermatol Ther. 2022 Dec;35(12):e15923. doi: 10.1111/dth.15923. Epub 2022 Oct 23.
8
Sweet syndrome after the first dose of SARS-CoV-2 vaccine (Pfizer-BioNTech).接种第一剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗（辉瑞-生物新技术公司）后出现的Sweet综合征。
Dermatol Ther. 2022 Dec;35(12):e15915. doi: 10.1111/dth.15915. Epub 2022 Oct 17.
9
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
10
Sweet syndrome following Moderna COVID-19 vaccine: A case report.接种莫德纳新冠疫苗后出现Sweet综合征：一例报告。
SAGE Open Med Case Rep. 2022 Aug 11;10:2050313X221117884. doi: 10.1177/2050313X221117884. eCollection 2022.
本文引用的文献
1
Cutaneous adverse effects of the available COVID-19 vaccines.现有 COVID-19 疫苗的皮肤不良反应。
Clin Dermatol. 2021 May-Jun;39(3):523-531. doi: 10.1016/j.clindermatol.2021.04.001. Epub 2021 Apr 27.
2
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.由新冠病毒辉瑞-BioNTech信使核糖核酸疫苗诱发的Sweet综合征。
Allergy. 2021 Oct;76(10):3194-3196. doi: 10.1111/all.14981. Epub 2021 Jul 3.
3
Sweet's syndrome triggered by pneumococcal vaccination.肺炎球菌疫苗接种引发的Sweet综合征。
Cutan Ocul Toxicol. 2013 Sep;32(3):260-1. doi: 10.3109/15569527.2012.759960. Epub 2013 Jan 25.
4
Sweet's syndrome: a review of current treatment options.斯威特综合征：当前治疗选择综述
Am J Clin Dermatol. 2002;3(2):117-31. doi: 10.2165/00128071-200203020-00005.
5
Acute febrile neutrophilic dermatosis (Sweet's syndrome) following BCG vaccination.
Acta Derm Venereol. 1986;66(4):357-8.
Zotero 插件